Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 473-390-7 | CAS number: -
Endpoint summary
Administrative data
Description of key information
A 28 Day Oral study has been conducted on FC-770 and two 90 Day Inhalation studies has been conducted on analogs of FC-770. The NOAEL in the 28 day study is 1000 mg/kg-day and the molecular weight adjusted NOAEL values for the 90 Day studies are is 59020 ppm and 66170 ppm.
Key value for chemical safety assessment
Additional information
In the 28 Day Oral study, animals were dosed at 250, 500 and 1000 mg/kg-day. At 1000 mg/kg-day, no effects were noted for body weight gain, food consumption, organ weight changes, gross pathology, neurobehavior, clinical chemistry or hematology. The NOAEL was determined to be 1000 mg/g-day, which was the highest dose tested.
In the first 90 day study, the analog substance (Perfluorohexane) was tested at nominal concentrations of 5000, 15000 and 50000 ppm. There were no toxicologically significant treatment-related signs of mortality, clinical signs of toxicity, bodyweight, food consumption, ophthalmoscopy, biochemistry, macroscopic pathology, organ weights and microscopic pathology. No effects of exposure were observed. From this study, a no observed adverse effect level (NOAEL) of 49821 ppm (molecular weight adjusted to 59020 ppm) (the highest measured dose) was determined.
In the second 90 day study, the analog substance (Perfluoro-N-methylmorpholine) was tested at 4971, 15094, and 49589 ppm.There were no toxicologically significant treatment-related signs of mortality, clinical signs of toxicity, bodyweight, food consumption, ophthalmoscopy, biochemistry, macroscopic pathology, organ weights and microscopic pathology.The No Observed Adverse Effect Level for the test article under the conditions of the study was 49589 ppm (molecular weight adjusted to 66170 ppm).
Justification for classification or non-classification
The results of these tests do not meet the requirement to classifyFC-770 as dangerous.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
